Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$10,200,023
+$4,750,678 QoQ
Shares Held
423,589
+118.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#423
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 54%
Shared 10%
None 36%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Savant Capital, LLC holds $304,795,936 across 15 Drug Manufacturers - General names. PFE ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,429 | $80,876,372 | |
| 2 | JNJ |
Johnson & Johnson
|
265,777 | $67,499,384 | |
| 3 | ABBV |
AbbVie Inc.
|
205,994 | $51,836,330 | |
| 4 | MRK |
Merck & Co., Inc.
|
220,270 | $28,304,695 | |
| 5 | NVS |
Novartis AG
|
150,968 | $23,659,704 | |
| 6 | AMGN |
Amgen Inc
|
40,234 | $14,569,536 | |
| 7 | PFE |
Pfizer Inc
This page
|
423,589 | $10,200,023 | |
| 8 | AZN |
Astrazeneca PLC
|
35,321 | $6,697,568 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,200,023 | 423,589 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $5,449,345 | 194,065 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $4,021,150 | 161,492 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,428,296 | 173,795 | Shares | Sole | 2026-03-04 | |
| 2025-06-30 | $3,846,888 | 158,700 | Shares | Sole | 2026-03-04 | |
| 2025-03-31 | $4,123,451 | 162,725 | Shares | Sole | 2026-03-04 | |
| 2024-12-31 | $6,222,054 | 234,529 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $7,307,060 | 252,490 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $6,113,210 | 218,485 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $6,447,324 | 232,336 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $6,144,390 | 213,421 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $7,347,088 | 221,498 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $8,033,250 | 219,009 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $5,825,342 | 142,778 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $9,266,549 | 180,846 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,211,287 | 96,236 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $4,955,526 | 94,517 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $4,715,522 | 91,086 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $5,329,675 | 90,257 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,654,473 | 84,968 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,925,330 | 74,702 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,417,410 | 66,724 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $2,448,122 | 66,507 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,485,761 | 67,732 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $2,237,009 | 68,410 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,372,859 | 72,698 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||